LHX2 and chronic myelogenous leukemia, BCR-ABL1 positive: The cells engrafting the stem cell-deficient mice maintain high level of expression of Lhx2 in vivo, which eventually leads to a chronic myeloproliferative disorder resembling human chronic myeloid leukemia [21].